Cost-effectiveness Analysis for Clinicians

<p>Cost-effectiveness analysis defines trade-offs between costs, harms, and benefits of alternative treatments and combines them into a single metric, the incremental cost-effectiveness ratio (ICER), that can inform decisions about which interventions to recommend when limited resources are available. Gillian Sanders-Schmidler, PhD, professor of population health sciences and medicine at Duke University, explains the method in terms clinicians can understand.</p> <p>Related Articles:</p> <ul> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.1265?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links"target=_"blank"rel="noopener""> Overview of Cost-effectiveness Analysis</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.1153?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links"target=_"blank"rel="noopener""> Choosing a Time Horizon in Cost and Cost-effectiveness Analyses</a></li> </ul>